Business · 09/07/2024Updated: 10/17/2026 · 1 min read
FDA Releases Revised Draft Guidance on Addressing Misinformation About Medical Devices and Prescription Drugs
Summary
The FDA has released a revised draft guidance for industry, which will provide answers to common questions firms have when addressing misinformation about their approved medical products, replacing a previous guidance issued in June 2014.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →